{rfName}
Ma

Indexed in

License and use

Icono OpenAccess

Citations

Altmetrics

Analysis of institutional authors

Rodríguez Nieto M.j.AuthorValenzuela C.Author

Share

February 21, 2022
Publications
>
Article
Sí

Management of Interstitial Lung Diseases (ILD) Associated with Autoimmune Diseases by the Pulmonologyst in the Differents ILD Units in Spain

Publicated to:Open Respiratory Archives. 4 (1): 100160- - 2022-01-01 4(1), DOI: 10.1016/j.opresp.2022.100160

Authors: Acosta Fernández O; Aburto Barrenetxea M; Llanos González AB; Rodríguez Nieto MJ; Molina Molina M; Valenzuela C

Affiliations

Hospital Universitari de Bellvitge - Author
Hospital Universitario de Canarias - Author
Hospital Universitario de la Princesa - Author
Hospital Universitario Fundacion Jimenez Diaz - Author
Universidad del País Vasco - Author
See more

Abstract

Introduction: The aim of the study was to know the management of patients with diffuse interstitial lung disease (ILD) associated with a systemic autoimmune diseases (SAD) in pulmonology outpatient clinics in Spain. Methodology: The ILD work area of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) designed a self-completed questionnaire of 25 questions, on aspects related to the diagnosis and treatment of ILD-SAD. This was distributed among the attendees of the winter meeting of the ILD Area and later via e-mail to all the members of the ILD area of SEPAR. Participation was anonymous, voluntary and without consideration. Results: 74 pulmonologists from 58 hospitals participated. 77% had a specialized ILD consultation. All Units with SEPAR accreditation had a committee made up of pulmonologists and radiologists and a majority participation of pathologists and rheumatologists. In 75% of the centers there was a close collaboration with Rheumatology for the management of ILD-SAD. 85% considered that the frequency of ILD-SAD consults is increasing, the most frequent being ILD associated with rheumatoid arthritis. The treatment of ILD-SAD is decided by consensus between pulmonologist and rheumatologist in 91.3% of the cases. 67% of pulmonologists consider that immunosuppressants and biological therapies can slow down the progression of ILD-SAD. 51% use antifibrotics therapies in these pathologies. Conclusions: Almost all of the accredited Spanish ILD Units by SEPAR have established collaborations with Rheumatology for the adequate management of patients with ILD-SAD, this practice having been extended to units not yet accredited.

Keywords

connective lung diseasesdiffuse interstitial lung diseasemultidisciplinary teampulmonary fibrosisrheumatic diseasesConnective lung diseasesDiffuse interstitial lung diseaseMultidisciplinary teamPulmonary fibrosisRheumatic diseasesSurvey

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Open Respiratory Archives, Q4 Agency Scopus (SJR), its regional focus and specialization in Pulmonary and Respiratory Medicine, give it significant recognition in a specific niche of scientific knowledge at an international level.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-02:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 19 (PlumX).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Assignment of a Handle/URN as an identifier within the deposit in the Institutional Repository: http://hdl.handle.net/10486/708010

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (VALENZUELA ., CLAUDIA).